StopAfib.org interviews Dr. Matthew Reynolds, of the Harvard Clinical Research Institute.
In this video interview, Dr. Reynolds talked about his research looking at outcomes and quality of life following catheter ablation. His research analyzed quality of life data that was collected as part of a previously-reported catheter trial, in which catheter ablation was found to be significantly more effective at maintaining sinus rhythm than antiarrhythmic drugs. In this trial, 160 paroxysmal atrial fibrillation patients who had already failed one antiarrhythmic drug were randomized to either another antiarrhythmic drug or to catheter ablation. Dr. Reynolds looked at the quality of life data collected in the trial and found that there were dramatic and meaningful differences. Dr. Reynolds is the Director of the Economics and Quality of Life Research Center at the Harvard Clinical Research Institute, Assistant Professor of Medicine at the Harvard Medical School, and Associate Director of Electrophysiology at the Boston VA Healthcare System.
Find more on this interview, and Dr. Reynolds, at: